483 Roundup: FDA Cites Five Firms for Quality, Other Violations

Drug GMP Report
A A
The FDA flagged four U.S. facilities and one in Switzerland for quality and other violations observed during agency inspections—from inadequate testing to incomplete records.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00